Aurora Cannabis Inc. closed 52.83% short of its 52-week high of $9.35, which the company reached on April 30th.

Aurora Cannabis Inc. closed 54.01% short of its 52-week high of $9.35, which the company achieved on April 30th.

Aurora Cannabis has transformed its margins, market position, and balance sheet over the last few years, and the stock is now highly 'investible'. ACB's strategic focus on the global medical ...

Has Aurora Cannabis Inc. (ACB) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer ...

Testing for cannabis is making it increasingly harder for maritime companies to hire employees . Pre-employment drug tests have been a staple in the ...

Canadian cannabis stock Aurora Cannabis (TSE:ACB) is stepping up its line of offerings in Australia, and bringing a new set of pastille products for customers down there. The news will prove ...

Investing.com - Wall Street was lower on Monday as investors waited for a trade tariff announcement from the White House. The ...

Aurora Cannabis (ACB) has announced today the company’s extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora’s deep commitment to offering patients ...

Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports.